Problematic use of prescription-type opioids prior to heroin use among young heroin injectors
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Misuse of prescription-type opioids and related adverse health effects are increasing, but little is known about the role of these drugs as a precursor to heroin use. We conducted an exploratory study to determine the proportion of young heroin injectors reporting problematic use of prescription-type opioids prior to using heroin, and to describe the factors associated with prior problematic prescription-type opioid use. METHODS: Between March 2009 and June 2010, we recruited injection drug users (IDUs) for a cross-sectional study of hepatitis C virus infection risk. Participants were aged 18-40 years and had injected illicit drugs within the previous six months. A computerized self-administered survey assessed sociodemographics, drug use history, human immunodeficiency virus (HIV)/hepatitis C virus risk behaviors and perceptions, and medical history. We added questions on prescription-type opioid use to the parent study in March 2010; heroin injectors who subsequently enrolled and reported problematic prescription-type opioid use prior to heroin initiation were compared with other heroin IDUs using univariate and multivariate regression methods. RESULTS: Among 123 heroin IDUs, 49 (39.8%) reported problematic prescription-type opioid use prior to heroin initiation ("prescription-type opioid first injection drug users" [PTO-First IDUs]). PTO-First IDUs had higher odds of injecting with friends (adjusted odds ratio [AOR] 6.01; 95% confidence interval [CI] 1.90-19.07), getting new syringes from a spouse/family member/sex partner (AOR 23.0; 95% CI 2.33-226.0), knowing about the local syringe exchange program (AOR 7.28; 95% CI 1.17-45.05), using powder cocaine (AOR 3.75; 95% CI 1.43-9.86), and perceiving themselves as less likely than other IDUs to get HIV (AOR 4.32; 95% CI 1.26-14.77). They had lower odds of ever being tested for HIV (AOR 0.25; 95% CI 0.08-0.80). CONCLUSION: A high proportion of young heroin IDUs reported problematic prescription-type opioid use prior to initiating heroin use. Our study provides several avenues for future investigation to help further characterize this subset of IDUs and their risks and perceptions related to HIV and other blood-borne pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initiation into prescription opioid misuse amongst young injection drug users
Lankenau, S. E., Teti, M., Silva, K., Bloom, J. J., Harocopos, A., & Treese, M. (2012) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2011.05.014 · Cited by 440 · cited 2×
“12,13 The findings from these three cities, in combination with previously published reports, 6–9, 14 indicate an urgent need for prospective We also found significant differences between the two groups with regard to HIV/HCV risk perceptions.”
Inciardi, J. A., Surratt, H. L., Cicero, T. J., & Beard, R. A. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00603.x · Cited by 229 · cited 1×
“A number of harm reduction interventions have targeted injection drug user networks.(8) Future studies should determine whether PTO-First injection networks differ from those of other heroin IDUs and, if so, what the implications are for network-based HIV/HCV prevention interventions.”
Illicit use of opioids: is OxyContin a “gateway drug”?
Grau, L. E., Dasgupta, N., Harvey, A. P., Irwin, K., Givens, A., Kinzly, M. L., & Heimer, R. (2007) · The American Journal on Addictions · doi:10.1080/10550490701375293 · Cited by 177
Siegal, H. A., Carlson, R. G., Wang, J., Falck, R. S., Stephens, R. C., & Nelson, E. D. (1994) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1994.10472440 · Cited by 25
Cited by
The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years
Cicero, T. J., Ellis, M. S., Surratt, H. L., & Kurtz, S. P. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.366 · Cited by 1,168
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1508490 · Cited by 1,044
Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures
Hill, M. V., McMahon, M. L., Stucke, R. S., & Barth, R. J. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001993 · Cited by 878
Treatment utilization among persons with opioid use disorder in the United States
Wu, L.-T., Zhu, H., & Swartz, M. S. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.015 · Cited by 340
Alpert, A., Powell, D., & Pacula, R. L. (2018) · American Economic Journal: Economic Policy · doi:10.1257/pol.20170082 · Cited by 323
Metadata
- Authors
- Pollini, R., Garfein, Banta-Green, Cuevas-Mota, Metzner, & Teshale
- Venue
- Substance Abuse and Rehabilitation
- Publisher
- Informa UK Limited
- Published
- 2011-10
- Volume
- 2
- Issue
- 1
- Pages
- 173
- ISSN
- 1179-8467 (ISSN-L)
- OpenAlex
- W2017412734
- Cited by
- 134
- References
- 4
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. https://app.cochat.ai/papers/10.2147/sar.s24800
- The paper
- Pollini, R., Garfein, Banta-Green, Cuevas-Mota, Metzner, & Teshale. (2011). Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Substance Abuse and Rehabilitation. https://doi.org/10.2147/sar.s24800
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.